“Diabesity” that is the new watch word for Biocon, according to Kiran Mazumdar Shaw, the famed promoter CEO of the company and Shaw is all set to position Biocon as the leading supplier of ...

Betting the Pharma: When Kiran Mazumdar-Shaw started Biocon in 1978, she had to beg banks in India for a line of credit. “There was no venture capital,” she says. “I was considered to be a ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted ...

This LNG will be used to operate Torrent’s 2,730 MW gas-based power plants. Biocon has received approval from Indian regulators for its version of Liraglutide, the active ingredient in Novo ...

Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon received the approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to market Yesintek ...

India's Biocon has expanded its pipeline of biosimilars with a $3.3 billion deal to acquire a portfolio of drugs from Viatris, the parent of its longstanding partner Mylan, which will boost its ...

But that's exactly what Kiran Mazumdar Shaw, the Executive Chairperson of Biocon, has done. She modestly keeps describing herself as an accidental entrepreneur. But reading between the lines of ...

Biocon shares are expected to be in focus on Tuesday after the company announced regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for its diabetes drug Liraglutide ...

WSJ’s Dan Gallagher explains how Nvidia’s quarterly revenue surged to a record $44 billion, despite its inability to ship $2.5 billion of chips due to Chinese market restrictions. Photo ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Biotech firm Biocon Ltd. on Tuesday said it has received approval from the government authorities for a generic diabetes medication. The company has received approval for its Liraglutide drug ...